Petrie M. Rainey - Concepedia

Author

Petrie M. Rainey

Also Known As

P M Rainey, P Rainey, P. M. Rainey, P. RAINEY, P.M. Rainey, PETRIE M. RAINEY, Petrie M Rainey, Petrie M. Rainey, Petrie M. Rainey MD, Petrie RAINEY

110

Publications

3.5K

Citations

H-Index

115

Concepts

All Affiliations

Yale University University of Washington University of California, San Francisco University of Utah University at Buffalo, State University of New York

About

Petrie M. Rainey is an author at Yale University specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	34	1.7K
2	Health Sciences	10	10	543
3	Natural Sciences	9	9	466
4	Engineering	1	1	24
5	Nursing	1	1	40

Petrie M. Rainey

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Cue-dose training with monetary reinforcement Michael O. Rigsby, Marc I. Rosen, John Beauvais, Journal of General Internal Medicine Behavioral SciencesSequential Decision MakingReward SystemCue-dose TrainingExploration V Exploitation	2000	213
Fisher Ratio Method Applied to Third-Order Separation Data To Identify Significant Chemical Components of Metabolite Extracts Karisa M. Pierce, Jamin C. Hoggard, Janiece L. Hope, Analytical Chemistry Metabolomic ProfilingGas ChromatographyBioanalysisAnalytical ChemistryBiostatistics	2006	151
In vitro antileishmanial properties of tri- and pentavalent antimonial preparations William L. Roberts, J D Berman, Petrie M. Rainey Antimicrobial Agents and Chemotherapy Bioorganic ChemistryAntiparasitic AgentMalariaChemical BiologyVisceral Leishmaniasis	1995	131
A cluster of cases of severe cardiotoxicity among kala-azar patients treated with a high-osmolarity lot of sodium antimony gluconate. Shyam Sundar, Pallavi Sinha, Neeraj Agrawal, American Journal of Tropical Medicine and Hygiene Heart FailureProlonged QtcCardiovascular PharmacologyPharmacotherapyCardiovascular Toxicity	1998	127
The Protease Inhibitor Lopinavir-Ritonavir May Produce Opiate Withdrawal in Methadone-Maintained Patients Elinore F. McCance‐Katz, Petrie M. Rainey, Gerald Friedland, Clinical Infectious Diseases	2003	126
Methadone Effects on Zidovudine Disposition (AIDS Clinical Trials Group 262) Elinore F. McCance‐Katz, Petrie M. Rainey, Peter Jatlow, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology Injection Drug UsersPharmacotherapyDrug TreatmentOral Zdv AucDrug Toxicity	1998	114
The effect of fluconazole on the clinical pharmacokinetics of methadone* Malik N. Cobb, Jay Desai, Lawrence S. Brown, Clinical Pharmacology & Therapeutics Drug SafetySubstance AbusePharmacological StudyMedicineAddiction	1998	98
Characterization of the Antimonial Antileishmanial Agent Meglumine Antimonate (Glucantime) William L. Roberts, Walter J. McMurray, Petrie M. Rainey Antimicrobial Agents and Chemotherapy	1998	94
Interaction between buprenorphine and atazanavir or atazanavir/ritonavir Elinore F. McCance‐Katz, David E. Moody, Gene D. Morse, Drug and Alcohol Dependence Molecular PharmacologyMedicineClinical PharmacologyPharmacotherapyPharmacology	2007	85
Interactions between Buprenorphine and Antiretrovirals. I. The Nonnucleoside Reverse-Transcriptase Inhibitors Efavirenz and Delavirdine Elinore F. McCance‐Katz, David E. Moody, Gene D. Morse, Clinical Infectious Diseases Opioid EpidemicDrug InteractionsOpiate DependenceHealth SciencesAddiction	2006	84

Page 1